<DOC>
	<DOCNO>NCT00445068</DOCNO>
	<brief_summary>This study evaluate efficacy safety LBH589B adult patient multiple myeloma receive least two prior therapy refractory last therapy . Patients must receive prior therapy either bortezomib lenalidomide</brief_summary>
	<brief_title>Efficacy Safety LBH589B Adult Patients With Multiple Myeloma</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Panobinostat</mesh_term>
	<criteria>Inclusion criterion : 1 . Adults ≥ 18 year old 2 . Diagnosis symptomatic multiple myeloma ( per IMWG see Kyle et al 2003 ) 3 . Subjects must receive least two prior line therapy refractory recent line therapy 4 . Subjects must previously treat : bortezomib lenalidomide 5 . Eastern Cooperative Oncology Group ( ECOG ) Performance Status ( PS ) ≤ 2 6 . Patients must adequate laboratory value 7 . Baseline leave ventricular ejection fraction LVEF ≥ low limit institutional normal Exclusion criterion : 1 . Prior therapy histone deacetylase inhibitor ( HDAC ) 2 . Impaired cardiac function clinically significant cardiac diseases 3 . Impairment gastrointestinal function ( GI ) function GI disease may significantly alter absorption LBH589 4 . Patients unresolved diarrhea &gt; Common Terminology Criteria Adverse Events ( CTCAE ) grade 1 5 . Concomitant use certain medication 6 . Patients receive chemotherapy , radiation therapy investigational drug , bortezomib immunomodulatory therapy immunotherapy ≤ 3 week prior start study drug recover side effect therapy 7 . Patients receive steroid ≤ 2 week prior start study treatment recover side effect therapy . 8 . Patients receive highdose corticosteroid component recent line therapy 9 . Patients undergone major surgery ≤ 4 week prior start study drug recover side effect therapy 10 . Women pregnant breast feed woman childbearing potential use effective method birth control . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Multiple myeloma</keyword>
	<keyword>adult</keyword>
	<keyword>LBH589</keyword>
	<keyword>refractory</keyword>
</DOC>